Frank Clyburn - 05 Aug 2024 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role: Director
Signature: /s/ Jack Anders, as Attorney-in-fact for Frank Clyburn
Issuer symbol: RVMD
Transactions as of: 05 Aug 2024
Net transactions value: $0
Form type: 4
Filing time: 07 Aug 2024, 17:34:49 UTC
Previous filing: 05 Mar 2024
Next filing: 01 Oct 2024
SEC: View on sec.gov

This filing has been restated, see here for the amended filing

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RVMD	Common Stock	Award	$0	+6,932		$0.000000	6,932	05 Aug 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RVMD	Stock Option (Right to Buy)	Award	$0	+27,744		$0.000000	27,744	05 Aug 2024	Common Stock	27,744	$42.48	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 6,932 restricted stock units.
F2	The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of August 5, 2024, subject to the reporting person's continued employment or service relationship with the Company on each such vesting date.